4114.TWSE: Synmosa Biopharma Corporation
Below is just a sample of the Company website (source: About Synmosa) Story Floods has reviewed with some preliminary suggestions. Should the Company decides to accept these edits, please extend the professional curtesy of informing Story Floods at support@storyfloods.com ; or if the Company has further questions, please also feel free to contact Story Floods at support@storyfloods.com
| Items | Suggest the Following Edits (as of July 31, 2022) |
|---|---|
| 1 | change to “including” |
| 2 | change to “The Company has” + suggest global change |
| 3 | change to “its corporate strategy of sustainable development: organic growths, continuous mergers and acquisitions, as well as strategic alliances,” |
| 4 | change to “lock onto niche market products. The Company now focuses on branded and new drugs. The key to continuous and stable growth is by focusing on the best high threshold special technologies and characteristic pharmaceuticals.” |
